Bristol Myers Squibb (BMY) is a publicly traded Healthcare sector company. As of August 18, 2026, BMY trades at $66.15 with a market cap of $132.02B and a P/E ratio of 14.53. BMY moved +2.27% today. Year to date, BMY is +22.45%; over the trailing twelve months it is +37.06%. Its 52-week range spans $42.52 to $68.10. Analyst consensus is buy with an average price target of $66.30. Rallies surfaces BMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
21 analysts cover BMY: 0 strong buy, 9 buy, 11 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $66.30.
| Metric | Value |
|---|---|
| Price | $66.15 |
| Market Cap | $132.02B |
| P/E Ratio | 14.53 |
| EPS | $4.56 |
| Dividend Yield | 0.63% |
| 52-Week High | $68.10 |
| 52-Week Low | $42.52 |
| Volume | 6.61M |
| Avg Volume | 0 |
| Revenue (TTM) | $49.19B |
| Net Income | $9.27B |
| Gross Margin | 70.16% |
21 analysts cover BMY: 0 strong buy, 9 buy, 11 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $66.30.